Implementation of guideline-informed care for the prevention, detection, and management of kidney disease remains suboptimal throughout the world. In November 2025, Kidney Disease: Improving Global Outcomes (KDIGO) held a Controversies Conference on the role of technology-supported solutions to improve guideline-inform...
J. Manski-Nankervis, Wisit Cheungpasitporn, A. Garg et al.· Kidney International· 1 citation
Abstract Artificial intelligence (AI) is reshaping kidney care by integrating electronic health records (EHRs), imaging, digital pathology, genomics, wearable biosensors, and longitudinal physiologic data into dynamic risk-prediction systems. Traditional nephrology risk stratification has relied on static variables and...
C. Thongprayoon, Noppawit Aiumtrakul, F. Pesce et al.· Risk Management and Healthca...· 0 citations
Because a model can outperform clinicians in aggregate yet fail where oversight is least likely to detect it, evaluation of clinical AI should weigh error structure alongside accuracy.
R. Bellocco, L. Soraci, Lorenzo Lo Cicero et al.· Epidemiology Biostatistics a...· 0 citations
Together, these trends suggest that AI-enabled regenerative and xenogeneic strategies may meaningfully reduce the organ shortage and support future progress toward precision-engineered organ replacement.
K. Solez, Habba F. Mahal, Wisit Cheungpasitporn et al.· Renal Failure· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.